Desafíos en el tratamiento del angiosarcoma

1.    Naka N., Ohsawa M., Tomita Y., et al:  Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases.  J Surg Oncol 61. 170-176.1996;
2.    Mark R.J., Poen J.C., Tran L.M., et al:  Angiosarcoma. A report of 67 patients and a review of the literature.  Cancer 77. 2400-2406.1996;
3.    Rouhani P., Fletcher C.D., Devesa S.S., et al:  Cutaneous soft tissue sarcoma incidence patterns in the U.S.: an analysis of 12,114 cases.  Cancer 113. 616-627.2008;
4.    Torosian M.H., Friedrich C., Godbold J., et al:  Soft-tissue sarcoma: initial characteristics and prognostic factors in patients with and without metastatic disease.  Semin Surg Oncol 4. 13-19.1988;
5.    Coindre J.M., Terrier P., Guillou L., et al:  Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group.  Cancer 91. 1914-1926.2001;
6.    Penel N., Grosjean J., Robin Y.M., et al:  Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases.  Sarcoma 2008. 459386.2008;
7.    Fury M.G., Antonescu C.R., Van Zee K.J., et al:  A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy.  Cancer J 11. 241-247.2005;
8.    Fayette J., Martin E., Piperno-Neumann S., et al:  Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases.  Ann Oncol 18. 2030-2036.2007;
9.    Abraham J.A., Hornicek F.J., Kaufman A.M., et al:  Treatment and outcome of 82 patients with angiosarcoma.  Ann Surg Oncol 14. 1953-1967.2007;
10.    Virtanen , Pukkala E., Auvinen A.:  Angiosarcoma after radiotherapy: a cohort study of 332,163 Finnish cancer patients.  Br J Cancer 97. 115-117.2007;
11.    Woodward A.H., Ivins J.C., Soule E.H.:  Lymphangiosarcoma arising in chronic lymphedematous extremities.  Cancer 30. 562-572.1972;
12.    Bosetti C., La Vecchia C., Lipworth L., et al:  Occupational exposure to vinyl chloride and cancer risk: a review of the epidemiologic literature.  Eur J Cancer Prev 12. 427-430.2003;
13.    Lipshutz G.S., Brennan T.V., Warren R.S.:  Thorotrast-induced liver neoplasia: a collective review.  J Am Coll Surg 195. 713-718.2002;
14.    Huang J., Mackillop W.J.:  Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma.  Cancer 92. 172-180.2001;
15.    Sordillo P.P., Chapman R., Hajdu S.I., et al:  Lymphangiosarcoma.  Cancer 48. 1674-1679.1981;
16.    Muller R., Hajdu S.I., Brennan M.F.:  Lymphangiosarcoma associated with chronic filarial lymphedema.  Cancer 59. 179-183.1987;
17.    Locker G.Y., Doroshow J.H., Zwelling L.A., et al:  The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature.  Medicine (Baltimore) 58. 48-64.1979;
18.    Ben-Izhak O., Kerner H., Brenner B., et al:  Angiosarcoma of the colon developing in a capsule of a foreign body. Report of a case with associated hemorrhagic diathesis.  Am J Clin Pathol 97. 416-420.1992;
19.    Weiss W.M., Riles T.S., Gouge T.H., et al:  Angiosarcoma at the site of a Dacron vascular prosthesis: a case report and literature review.  J Vasc Surg 14. 87-91.1991;
20.    McDonald D.J., Enneking W.F., Sundaram M.:  Metal-associated angiosarcoma of bone: report of two cases and review of the literature.  Clin Orthop Relat Res 396. 206-214.2002;
21.    Fanburg J.C., Meis-Kindblom J.M., Rosenberg A.E.:  Multiple enchondromas associated with spindle-cell hemangioendotheliomas. An overlooked variant of Maffucci's syndrome.  Am J Surg Pathol 19. 1029-1038.1995;
22.    Weiss S.W., Goldblum J.R.:  Enzinger and Weiss's Soft Tissue Tumors.  Mosby-Year Book, Inc,St. Louis, MO2008. 
23.    West J.G., Weitzel J.N., Tao M.L., et al:  BRCA mutations and the risk of angiosarcoma after breast cancer treatment.  Clin Breast Cancer 8. 533-537.2008;
24.    Penel N., Bui B.N., Bay J.O., et al:  Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.  J Clin Oncol 26. 5269-5274.2008;
25.    Penel N., Van Glabbeke M., Marreaud S., et al:  Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years.  Ann Oncol 22. 1266-1272.2011;
26.    Schlemmer M., Reichardt P., Verweij J., et al:  Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.  Eur J Cancer 44. 2433-2436.2008;
27.    Ray-Coquard I., Italiano A., Bompas E., et al:  Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO). Oncologist 17. 260-266.2012;
28.    Maki R.G., D'Adamo D.R., Keohan M.L., et al:  Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.  J Clin Oncol 27. 3133-3140.2009;
29.    Park M.S., Ravi V., Araujo D.M.:  Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor.  Curr Opin Oncol 22. 351-355.2010;
30.    Agulnik M., Yarber J.L., Okuno S.H., et al:  An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 24. 257-263.2013